Amide analogues of CD1d agonists modulate i NKT-cell-mediated cytokine production

ACS Chemical Biology

Volumn 7, Issue 5, 2012, Pages 847-855

  Wojno, Justyna ^a,c   Jukes, John Paul ^b   Ghadbane, Hemza ^b   Shepherd, Dawn ^b   Besra, Gurdyal S ^a   Cerundolo, Vincenzo ^b   Cox, Liam R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; CARBAMIC ACID DERIVATIVE; CD1D ANTIGEN AGONIST; CERAMIDE DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 4; THIOAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CYTOKINE PRODUCTION; HYDROGEN BOND; INVARIANT NATURAL KILLER CELL; MOLECULAR MECHANICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS;

ANIMALS; ANTIGENS, CD1D; CHICK EMBRYO; CRYSTALLOGRAPHY, X-RAY; CYTOKINES; GALACTOSYLCERAMIDES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; NATURAL KILLER T-CELLS; SUGAR ALCOHOLS;

MURINAE; MUS;

EID: 84862067340     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb2005017     Document Type: Article

References (39)

1. Matsuda, J. L., Mallevaey, T., Scott-Brown, J., and Gapin, L. (2008) CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system Curr. Opin. Immunol. 20, 358-368
2. Venkataswamy, M. M. and Porcelli, S. A. (2010) Lipid and glycolipid antigens of CD1d-restricted natural killer T cells Semin. Immunol. 22, 68-78
3. Cerundolo, V., Silk, J. D., Masri, S. H., and Salio, M. (2009) Harnessing invariant NKT cells in vaccination strategies Nat. Rev. Immunol. 9, 28-38
4. Cerundolo, V., Barral, P., and Batista, F. D. (2010) Synthetic iNKT cell-agonists as vaccine adjuvants finding the balance Curr. Opin. Immunol. 22, 417-424
5. Taniguchi, M., Tashiro, T., Dashtsoodol, N., Hongo, N., and Watarai, H. (2010) The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy Int. Immunol. 22, 1-6
6. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H., and Taniguchi, M. (1997) CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides Science 278, 1626-1629 (Pubitemid 27516282)
7. See for example: Sada-Ovalle, I., Skold, M., Tian, T., Besra, G. S., and Behar, S. M. (2010) alpha-Galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection Am. J. Resp. Crit. Care 182, 841-847
8. Parekh, V. V., Wilson, M. T., Olivares-Villagómez, D., Singh, A. K., Wu, L., Wang, C.-R., Joyce, S., and van Kaer, L. (2005) Glycolipid antigen induces long-term natural killer T cell anergy in mice J. Clin. Invest. 115, 2572-2583 (Pubitemid 41266220)
9. For an approach to addressing this problem: Parekh, V. V., Lalani, S., Kim, S., Halder, R., Azuma, M., Yagita, H., Kumar, V., Wu, L., and van Kaer, L. (2009) PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells J. Immunol. 182, 2816-2826
10. Silk, J. D., Salio, M., Reddy, B. G., Shepherd, D., Gileadi, U., Brown, J., Masri, S. H., Polzella, P., Ritter, G., Besra, G. S., Jones, E. Y., Schmidt, R. R., and Cerundolo, V. (2008) Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells J. Immunol. 180, 6452-6456
11. Banchet-Cadeddu, A., Hénon, E., Dauchez, M, Renault, J.-H, Monneaux, F., and Haudrechy, A. (2011) The stimulating adventure of KRN7000 Org. Biomol. Chem. 9, 3080-3104
12. Lee, T., Cho, M., Ko, S.-Y., Youn, H.-J., Baek, D. J., Cho, W.-J., Kang, C.-Y., and Kim, S. (2007) Synthesis and evaluation of 1,2,3-triazole containing analogs of the immunostimulant α-GalCer J. Med. Chem. 50, 585-589 (Pubitemid 46239791)
13. Shiozaki, M., Tashiro, T., Koshino, H., Nakagawa, R., Inoue, S., Shigeura, T., Watarai, H., Taniguchi, M., and Mori, K. (2010) Synthesis and biological activity of ester and ether analogs of α-galactosylceramide (KRN7000) Carbohydr. Res. 345, 1663-1684
14. Koch, M., Stronge, V. S., Shepherd, D., Gadola, S. D., Mathew, B., Ritter, G., Fersht, A. R., Besra, G. S., Schmidt, R. R., Jones, E. Y., and Cerundolo, V. (2005) The crystal structure of human CD1d with and without α-galactosylceramide Nat. Immunol. 6, 819-826 (Pubitemid 43090468)
15. Pellicci, D. G., Patel, O., Kjer-Nielsen, L., Pang, S. S., Sullivan, L. C., Kyparissoudis, K., Brooks, A. G., Reid, H. H., Gras, S., Lucet, I. S., Koh, R., Smyth, M. J., Mallevaey, T., Matsuda, J. L., Gapin, L., McCluskey, J., Godfrey, D. I., and Rossjohn, J. (2009) Differential recognition of CD1d-α-galactosyl ceramide by the Vβ8.2 and Vβ7 semi-invariant NKT T cell receptors Immunity 31, 47-59
16. Borg, N. A., Wun, K. S., Kjer-Nielsen, L., Wilce, M. C. J., Pellicci, D. G., Koh, R., Besra, G. S., Bharadwaj, M., Godfrey, D. I., McCluskey, J., and Rossjohn, J. (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor Nature 448, 44-49 (Pubitemid 47037002)
17. See also: Wun, K. S., Cameron, G., Patel, O., Pang, S. S., Pellicci, D. G., Sullivan, L. C., Keshipeddy, S., Young, M. H., Uldrich, A. P., Thakur, M. S., Richardson, S. K., Howell, A. R., Illarionov, P. A., Brooks, A. G., Besra, G. S., McCluskey, J., Gapin, L., Porcelli, S. A., Godfrey, D. I., and Rossjohn, J. (2011) A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells Immunity 34, 327-339
18. Sullivan, B. A., Nagarajan, N. A., Wingender, G., Wang, J., Scott, I., Tsuji, M., Franck, R. W., Porcelli, S. A., Zajonc, D. M., and Kronenberg, M. (2010) Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14 i NKT cells J. Immunol. 184, 141-153
19. Schiefner, A., Fujio, M., Wu, D., Wong, C.-H., and Wilson, I. A. (2009) Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory Ligands J. Mol. Biol. 394, 71-82
20. Sandström, J. (1967) Barriers to internal rotation in thioamides. Experimental results and molecular orbital calculations J. Phys. Chem. 71, 2318-2325
21. Walter, W. and Becker, R. F. (1969) On structure of thioamides and their derivatives. VII. Acidity of aromatically substituted thioamides Liebigs Ann. Chem. 727, 71-80
22. Alemán, C. (2001) On the ability of modified peptide links to form hydrogen bonds J. Chem. Phys. A 105, 6717-6723 (Pubitemid 35378093)
23. Chen, P. and Qu, J. (2011) Backbone modification of β-hairpin- forming tetrapeptides in asymmetric acyl transfer reactions J. Org. Chem. 76, 2994-3004 and references therein
24. Fischer, L., Semetey, V., Lozano, J.-M., Schaffner, A.-P., Briand, J.-P., Didierjean, C., and Guichard, G. (2007) Succinimidyl carbamate derivatives from N -protected α-amino acids and dipeptides-synthesis of ureidopeptides and oligourea/peptide hybrids Eur. J. Org. Chem. 2511-2525 and references therein
25. Cho, C. Y., Moran, E. J., Cherry, S. R., Stephens, J. C., Fodor, S. P. A, Adams, C. L., Sundaram, A., Jacobs, J. W., and Schultz, P. G. (1993) An unnatural biopolymer Science 261, 1303-1305 (Pubitemid 24082271)
26. Reddy, B. G., Silk, J. D., Salio, M., Balamurugan, R., Shepherd, D., Ritter, G., Cerundolo, V., and Schmidt, R. R. (2009) Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants ChemMedChem 4, 171-178
27. H2 bias of natural killer T cells Nature 413, 531-534 (Pubitemid 32938752)
28. h2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo Int. Immunol. 17, 1619-1629 (Pubitemid 41754684)
29. McCarthy, C., Shepherd, D., Fleire, S., Stronge, V. S., Koch., M., Illarionov, P. A., Bossi, G., Salio, M., Denkberg, G., Reddington, F., Tarlton, A., Reddy, B. G., Schmidt, R. R., Reiter, Y., Griffi, G. M., van der Merwe, P. A., Besra, G. S., Jones, E. Y., Batista, F. D., and Cerundolo, V. (2007) The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation J. Exp. Med. 204, 1131-1144 (Pubitemid 46798156)
30. Karadimitris, A., Gadola, S., Altamirano, M., Brown, D., Woolfson, A., Klenerman, P., Chen, J. L., Koezuka, Y., Roberts, I. A. G., Price, D. A., Dusheiko, G., Milstein, C., Fersht, A., Luzzatto, L., and Cerundolo, V. (2001) Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography Proc. Natl. Acad. Sci. U.S.A. 98, 3294-3298 (Pubitemid 32220839)
31. Chang, Y.-J., Huang, J.-R., Tsai, Y.-C., Hung, J.-T., Wu, D., Fujio, M., Wong, C.-H., and Yu, A. L. (2007) Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids Proc. Natl. Acad. Sci. U.S.A. 104, 10299-10304 (Pubitemid 47185659)
32. Lu, X., Song, L., Metelitsa, L. S., and Bittman, R. (2006) Synthesis and evaluation of an α- C -galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells ChemBioChem 7, 1750-1756 (Pubitemid 44748660)
33. Schmieg, J., Yang, G. L., Franck, R. W., and Tsuji, M. (2003) Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide J. Exp. Med. 198, 1631-1641 (Pubitemid 37494156)
34. h1-biased cytokine production by α-carba-GalCer, a neoglycolipid ligand for NKT cells Int. Immunol. 22, 319-328
35. Oki, S., Chiba, A., Yamamura, T., and Miyake, S. (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells J. Clin. Invest. 113, 1631-1640 (Pubitemid 39071687)
36. Stanic, A. K., Shashidharamurthy, R., Bezbradica, J. S., Matsuki, N., Yoshimura, Y., Miyake, S., Choi, E. Y., Schell, T. D., Van Kaer, L., Tevethia, S. S., Roopenian, D. C., Yamamura, T., and Joyce, S. (2003) Another view of T cell antigen recognition: Cooperative engagement of glycolipid antigens by Va14Ja18 natural TCR J. Immunol. 171, 4539-4551 (Pubitemid 37310569)
37. Matsuda, J. L., Gapin, L., Baron, J. L., Sidobre, S., Stetson, D. B., Mohrs, M., Locksley, R. M., and Kronenberg, M. (2003) Mouse Vα4 i natural killer T cells are resistant to cytokine polarization in vivo Proc. Natl. Acad. Sci. U.S.A. 100, 8395-8400 (Pubitemid 36842556)
38. Dunbar, P. R., Ogg, G. S., Chen, J., Rust, N., van der Bruggen, P., and Cerundolo., V. (1998) Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood Curr. Biol. 8, 413-416 (Pubitemid 28174001)
39. Boulter, J. M., Glick, M., Todorov, P. T., Baston, E., Sami, M., Rizkallah, P., and Jakobsen, B. K. (2003) Stable, soluble T-cell receptor molecules for crystallization and therapeutics Protein Eng. 16, 707-711 (Pubitemid 37314399)